ASM Microbe 2017 | Events
This event has passed.

Join us at ASM Microbe 2017

June 1–5, 2017    |    New Orleans    |    Booth 2419
  • Experience the technology through our interactive demonstration
  • Learn about the reporting features of Accelerate Pheno™ System
  • See the instrument and user interface in action
  • One-on-one meetings with key team members
Learn more about evaluation and verification for blood culture:

Industry & Science Showcase

Sponsored by Accelerate Diagnostics

This Industry & Science Showcase is a promotional activity and is not approved for continuing education credit. The content of this presentation and opinions expressed by presenters are those of the organizer or presenters and not of ASM.


Phenotypic Antibiotic Susceptibility Testing Direct from Positive Blood Culture: Implications for Patient Treatment & Antimicrobial Stewardship
Where:

Ernest N. Morial Convention Center
Theatre A
New Orleans, LA

When:

Friday, June 2, 2017
1:30 – 2:15 p.m.

1:30 – 1:50 p.m.
The Potential Impact of Rapid Phenotypic Susceptibilities on the Management of Patients with Gram Negative Sepsis

Presented by Paula Revell, PhD, D(ABMM)
Assistant Professor, Pathology & Immunology and Pediatrics,
Baylor College of Medicine
Clinical Liaison, Medical Microbiology Laboratories
Texas Children's Hospital, Houston TX

1:50 – 2:10 p.m.
Integration of New Phenotypic Antibiotic Susceptibility Technology with Antimicrobial Stewardship in a Community Hospital Setting

Presented by Ioana Chirca, MD
Infectious Diseases Specialist
Chair, Antimicrobial Stewardship Committee
University Hospital, Augusta, GA


Fast Phenotypic Susceptibility Testing: From Laboratory to Clinician to Patient
Where:

Ernest N. Morial Convention Center
Theatre A
New Orleans, LA

When:

Saturday, June 3, 2017
12:30 – 1:15 p.m.

12:30 – 12:50 p.m.
Fast Phenotypic Antibiotic Susceptibilities for Positive Blood Cultures: Clinical Implementation considerations for the Microbiology Laboratory

Presented by Carey-Ann Burnham, Ph.D., D(ABMM), F(CCM)
Associate Professor, Pathology & Immunology, Molecular Microbiology, Pediatrics
Washington University School of Medicine, St Louis MO
Medical Director, Clinical Microbiology
Barnes-Jewish Hospital, St Louis, MO

12:50 – 1:10 p.m.
Early Directed Antibiotic Treatment of Patients with Sepsis:
Potential Impact of Fast Susceptibility Results on Patients with Bacteremia

Presented by Marin H. Kollef, MD, FACP, FCCP
Professor, Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis MO
Director, Medical Intensive Care Unit, Barnes-Jewish Hospital
Director, Respiratory Care Services, Barnes-Jewish Hospital, St. Louis MO


Poster Presentations

Date:
Friday, June 2

Time:
12:45 p.m. – 2:45 p.m.

444 - A Case Report of E. coli Bacteremia Detection Direct from a Whole Blood Patient Sample Using the Accelerate Pheno™ System

I. Yushkevich, S. Giddins, M. Mensack, K. Hance, A. Irwin, A. Jeffers, M. Barron, C. Price MD, S. Metzger
Denver Health and Hospital Authority

449 - Rapid Detection of Enterobacteriaceae Direct From Blood on Simulated Bacteremia Samples Using the Accelerate Pheno™ System

I. Yushkevich, S. Giddins, M. Mensack, K. Hance, A. Irwin, C. Price MD, S. Metzger
Denver Health and Hospital Authority

487 - Performance of a Novel System for Rapid Identification and Susceptibility Testing Directly from Positive Pediatric Blood Cultures

M. Gonzalez, J. Vong, R. Jerris, and E. McElvania TeKippe
Children’s Medical Center Dallas and Children's Healthcare of Atlanta

CPHM LB2 - Evaluation of the Accelerate Pheno™ System: Results of a Large Academic Medical Center

C. Bittencourt, E. McElvania TeKippe, D. Cavuoti, Joseph D. Lutgring, E. Burd, R. Hollaway
UT Southwestern Medical Center and Emory University Hospital

Date:
Saturday, June 3

Time:
12:15 p.m. – 2:15 p.m.

CPHM LB2 - Clinical Performance of an Innovative System for Rapid Microbe Identification & Antimicrobial Susceptibility Testing from Positive Blood Cultures, Including a Unique Monomicrobial Designation

D. Hernandez, K. Rygalski, A. Styer, M. Updike, and D.M. Wolk
Geisinger Health System

414 - A Novel System for Microbial Identification and Susceptibility Testing Directly from Clinical Blood Culture Samples

P. Lüthje, M. Ullberg, V. Ozenci
Karolinska University Hospital

440 - Accelerate PhenoTest™ BC Kit vs. Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram‐positive Bloodstream Isolates: Implications for Antimicrobial Stewardship

Amelia K. Sofjan, Benjamin O. Casey, Boxin A. Xu, Jonathan Amadio, Alejandro Restrepo, M. Jahangir Alam, Kevin W. Garey
University of Houston College of Pharmacy

450 - Evaluation of the Accelerate Pheno System for the Rapid Identification and Susceptibility of Gram-Negative Rods from Positive Blood Cultures

C. Johnson Ph.D., A. Davis, R. Riordan, A. Rivera-Acosta, M. Castillo De Tunon, J. Dunn Ph.D. and P. Revell, Ph.D.
Texas Children’s Hospital

454 - Evaluation of an Automated Platform for Rapid Identification and Antibiotic Sensitivity Testing of Bacteria Directly from Positive Blood Culture Bottles

R. Nudell, K. Belkowski, J. Gay, D. Downey, T. E. Schutzbank
St. John Hospital and Medical Center

455 - Use of Accelerate Pheno™ System for the Identification and Susceptibility (ID/AST) of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow

V. Tesic, B. Hill, N. Love, S. Boonlayangoor, A. Charnot-Katsikas, K.G. Beavis
University of Chicago Medicine

Recent Publications

Oct 20, 2017

Analytical Performance Characteristics of the Accelerate PhenoTM system for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia
IDWeek 2017

Oct 20, 2017

Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate PhenoTM system
IDWeek 2017

Oct 20, 2017

Accelerating Time to Pathogen-adapted Antibiotic Treatment through Culture- independent Antimicrobial Susceptibility Testing in Patients suffering from Sepsis
IDWeek 2017

Oct 20, 2017

Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ system (AXDX) for Gram-negative (GNB) Bloodstream Infections
IDWeek 2017

See all publications

Learn about our

Technology

What it’s like

Inside Accelerate